{"id":"tenecteplase-thrombolysis","safety":{"commonSideEffects":[{"rate":null,"effect":"Bleeding (major and minor)"},{"rate":null,"effect":"Intracranial hemorrhage"},{"rate":null,"effect":"Hypotension"},{"rate":null,"effect":"Arrhythmias"}]},"_chembl":{"chemblId":"CHEMBL2108791","moleculeType":"Enzyme"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Tenecteplase is a genetically engineered variant of tissue plasminogen activator (tPA) with enhanced fibrin specificity and longer half-life. It binds to fibrin in thrombi and catalyzes the conversion of plasminogen to plasmin, which degrades the fibrin matrix of blood clots. This mechanism enables rapid thrombolysis in acute thrombotic conditions such as acute myocardial infarction and acute ischemic stroke.","oneSentence":"Tenecteplase is a fibrin-specific thrombolytic agent that converts plasminogen to plasmin, dissolving blood clots by breaking down fibrin.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:11:30.053Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute myocardial infarction"},{"name":"Acute ischemic stroke"}]},"trialDetails":[{"nctId":"NCT07471256","phase":"PHASE3","title":"Neuronavigation-assisted Stereotactic Minimally Invasive Puncture With Tenecteplase for Acute Lobar Intracerebral Hemorrhage","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2026-03-31","conditions":"Intracerebral Hemorrhage Lobar","enrollment":636},{"nctId":"NCT07294209","phase":"PHASE4","title":"Low-Dose Tenecteplase for Acute Ischemic Stroke Treatment in Aging Patients","status":"RECRUITING","sponsor":"Southwest Hospital, China","startDate":"2025-12-19","conditions":"Acute Ischemic Stroke Patients","enrollment":798},{"nctId":"NCT07469293","phase":"PHASE3","title":"Efficacy and Safety of Intra-arterial Tenecteplase in Acute Ischemic Stroke Patients With Medium Vessel Occlusion Stroke (DATE-MeVO)","status":"NOT_YET_RECRUITING","sponsor":"Southwest Hospital, China","startDate":"2026-03-25","conditions":"Acute Ischemic Stroke","enrollment":488},{"nctId":"NCT07203625","phase":"PHASE4","title":"Tenecteplase Before Interhospital Transfer in Acute Basilar Artery Occlusion at 4.5 to 24 Hours","status":"RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2026-01-20","conditions":"Acute Ischemic Stroke, Basilar Artery Occlusion","enrollment":316},{"nctId":"NCT07476898","phase":"PHASE3","title":"Precision Reperfusion Therapy for Disabling Minor Stroke With Large Vessel Occlusion Beyond Time Window","status":"NOT_YET_RECRUITING","sponsor":"First Hospital of China Medical University","startDate":"2026-03-01","conditions":"Stroke","enrollment":864},{"nctId":"NCT07475949","phase":"PHASE3","title":"Unknown Time of Onset Stroke RePerfusIon Without Advanced Imaging","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital of Guangxi Medical University","startDate":"2026-04","conditions":"Acute Ischemic Stroke, Tenecteplase","enrollment":352},{"nctId":"NCT07475936","phase":"","title":"Intravenous Tenecteplase in Very Old Patients With Acute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital of Guangxi Medical University","startDate":"2026-04","conditions":"Acute Ischemic Stroke, Tenecteplase","enrollment":392},{"nctId":"NCT07471282","phase":"PHASE3","title":"Reperfusion Completion Via Local Arterial Infusion of Tenecteplase After Incomplete Mechanical Thrombectomy","status":"NOT_YET_RECRUITING","sponsor":"Chuansheng Zhao","startDate":"2026-03-01","conditions":"Stroke","enrollment":344},{"nctId":"NCT07460713","phase":"NA","title":"Advancing Reperfusion Therapy for Ischemic Stroke: Direct Transfer to Angiography Suite for Patients With Suspected Large Vessel Occlusion","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2026-03-31","conditions":"Ischemic Stroke, Large Vessel Occlusion","enrollment":568},{"nctId":"NCT06018181","phase":"","title":"Outcomes After Intravenous Alteplase / Tenecteplase With or Without Shuxuetong Injection in Routine Clinical Practice","status":"COMPLETED","sponsor":"Dongzhimen Hospital, Beijing","startDate":"2023-09-28","conditions":"Ischemic Stroke, Acute","enrollment":2408},{"nctId":"NCT06241677","phase":"NA","title":"Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients on DOAC","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2024-04-15","conditions":"CVA (Cerebrovascular Accident)","enrollment":260},{"nctId":"NCT07375953","phase":"PHASE2","title":"Repeated Intravenous Thrombolysis for Ischemic Stroke Within 3.0 Hours of Onset With Tenecteplase (RITIS-TNK)","status":"NOT_YET_RECRUITING","sponsor":"General Hospital of Shenyang Military Region","startDate":"2026-03-01","conditions":"Ischemic Stroke","enrollment":120},{"nctId":"NCT07375966","phase":"PHASE2","title":"Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours of Onset With Tenecteplase (RITIS-TNK2)","status":"NOT_YET_RECRUITING","sponsor":"General Hospital of Shenyang Military Region","startDate":"2026-03-01","conditions":"Ischemic Stroke","enrollment":198},{"nctId":"NCT07419997","phase":"","title":"A Multicenter, Retrospective, Observational Cohort Study on Intravenous Thrombolysis Beyond the Time Window for Acute Ischemic Stroke","status":"RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2025-12-29","conditions":"Stroke","enrollment":2600},{"nctId":"NCT07357987","phase":"PHASE3","title":"Intra-arterial Tenecteplase for Acute Medium Vessel Occlusion Stroke","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2026-01-22","conditions":"Ischemic Stroke, Medium Vessel Occlusion, Tenecteplase","enrollment":488},{"nctId":"NCT07302854","phase":"PHASE2, PHASE3","title":"Intra-arterial Recombinant Human Tenecteplase Tissue-type Plasminogen Activator (rhTNK-tPA) Thrombolysis for Acute Medium Vessel Occlusion","status":"RECRUITING","sponsor":"Xiang Luo","startDate":"2025-12-30","conditions":"Acute Ischemic Stroke, Medium Vessel Occlusion","enrollment":382},{"nctId":"NCT06949228","phase":"PHASE2, PHASE3","title":"Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy (ALLY) II Trial","status":"RECRUITING","sponsor":"ProMedica Health System","startDate":"2025-07-30","conditions":"Ischemic Stroke, Acute Disease","enrollment":132},{"nctId":"NCT07347626","phase":"PHASE3","title":"Eptifibatide for Extended Window Ischemic Stroke After Thrombolysis","status":"NOT_YET_RECRUITING","sponsor":"Xinqiao Hospital of Chongqing","startDate":"2026-03-01","conditions":"Acute Ischemic Stroke","enrollment":786},{"nctId":"NCT06904911","phase":"PHASE2","title":"Intra-Arterial Tenecteplase to Improve the Microvascular Hemodynamics After Mechanical Thrombectomy","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2025-12-11","conditions":"Acute Ischemic Stroke From Large Vessel Occlusion","enrollment":20},{"nctId":"NCT07271342","phase":"","title":"Observational RegIstry of Effectiveness and Safety of teNecTeplase in reAl worLd Settings in China","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-11-30","conditions":"Stroke","enrollment":10000},{"nctId":"NCT07318948","phase":"NA","title":"BALANCE Trial Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632","status":"NOT_YET_RECRUITING","sponsor":"Bo Wu","startDate":"2026-01-01","conditions":"Acute Ischemic Stroke","enrollment":1600},{"nctId":"NCT06210633","phase":"","title":"Prospective Registry of Endovascular Thrombectomy for eXtra-Large Ischemic Stroke","status":"RECRUITING","sponsor":"Zhongming Qiu","startDate":"2024-01-20","conditions":"Acute Ischemic Stroke (AIS), Acute Ischemic Stroke From Large Vessel Occlusion","enrollment":1000},{"nctId":"NCT05604638","phase":"PHASE3","title":"Early Administration of Tirofiban in Patients Treated With Tenecteplase for Acute Ischemic Stroke","status":"RECRUITING","sponsor":"Second Affiliated Hospital of Guangxi Medical University","startDate":"2024-04-24","conditions":"Acute Ischemic Stroke","enrollment":348},{"nctId":"NCT07092709","phase":"PHASE3","title":"Tenecteplase for Intravenous Stroke Thrombolysis in Recent DOAC Users","status":"RECRUITING","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2025-08-14","conditions":"Acute Ischemic Stroke","enrollment":912},{"nctId":"NCT07208097","phase":"NA","title":"Stereotactic Thrombolysis With Tenecteplase for Supratentorial Intracerebral Hemorrhage","status":"RECRUITING","sponsor":"Tongji Hospital","startDate":"2025-10-25","conditions":"Intracerebral Haemorrhage, Minimally Invasive Treatment","enrollment":768},{"nctId":"NCT05363397","phase":"PHASE2","title":"Safety and Tolerability of Adjunctive TBO-309 in Reperfusion for Stroke","status":"RECRUITING","sponsor":"The Florey Institute of Neuroscience and Mental Health","startDate":"2023-09-27","conditions":"Acute Ischemic Stroke","enrollment":80},{"nctId":"NCT06221371","phase":"PHASE3","title":"Endovascular Treatment With or Without Preceding Intravenous Tenecteplase (TNK) in Patients With Late-window acUte Ischemic Stroke Due to Middle Cerebral Artery Occlusion","status":"COMPLETED","sponsor":"Beijing Tiantan Hospital","startDate":"2024-01-25","conditions":"Ischemic Stroke, Acute, Thrombolysis, Endovascular Treatment","enrollment":391},{"nctId":"NCT04526951","phase":"PHASE3","title":"TENecteplase in Central Retinal Artery Occlusion Stuy (TenCRAOS)","status":"COMPLETED","sponsor":"Oslo University Hospital","startDate":"2020-10-30","conditions":"Central Retinal Artery Occlusion","enrollment":81},{"nctId":"NCT07185022","phase":"NA","title":"Intra-arterial Thrombolysis for Acute Ischemic Stroke With Medium Vessel Occlusion","status":"NOT_YET_RECRUITING","sponsor":"The Second Hospital of Anhui Medical University","startDate":"2025-10-01","conditions":"Stroke, Cerebrovascular Disorders, Brain Diseases","enrollment":282},{"nctId":"NCT07160491","phase":"NA","title":"Early Thrombolysis Guided by AI-Assisted App in Patients With STEMI","status":"RECRUITING","sponsor":"Shenyang Northern Hospital","startDate":"2025-09-08","conditions":"STEMI - ST Elevation Myocardial Infarction","enrollment":3356},{"nctId":"NCT06320431","phase":"PHASE3","title":"ACT-GLOBAL THROMBOLYSIS (ACT-WHEN-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632","status":"RECRUITING","sponsor":"University of Calgary","startDate":"2024-09-26","conditions":"Acute Ischemic Stroke AIS, Stroke Acute, Stroke, Acute, Stroke Ischemic","enrollment":4000},{"nctId":"NCT06878066","phase":"PHASE3","title":"Thrombolysis in Factor Xa-inhibitors Trial","status":"RECRUITING","sponsor":"Guri Hagberg","startDate":"2025-03-14","conditions":"Stroke, Stroke (in Patients With Atrial Fibrillation), Ischemic Stroke","enrollment":300},{"nctId":"NCT06010628","phase":"PHASE4","title":"Tenecteplase for Acute Ischemic Stroke Within 4.5 to 6 Hours of Onset (EXIT-BT2)","status":"RECRUITING","sponsor":"General Hospital of Shenyang Military Region","startDate":"2024-02-01","conditions":"Stroke, Ischemic","enrollment":1440},{"nctId":"NCT07094763","phase":"NA","title":"Efficacy and Safety of Tenecteplase Intravenous Thrombolysis in Acute Posterior Circulation Ischemic Stroke Within 4.5-24 Hours After Onset","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital of University of Science and Technology of China","startDate":"2025-08-05","conditions":"Acute Ischemic Stroke","enrollment":406},{"nctId":"NCT05892510","phase":"PHASE2, PHASE3","title":"Post-thrombectomy Intra-arterial Tenecteplase for Acute manaGement of Non-retrievable Thrombus and No-reflow in Emergent Stroke","status":"RECRUITING","sponsor":"University of Melbourne","startDate":"2024-06-01","conditions":"Ischemic Stroke, Acute, Cerebrovascular Disorders, Brain Disorder","enrollment":462},{"nctId":"NCT06414499","phase":"PHASE3","title":"Teneteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-Ⅳ","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-07-09","conditions":"Minor Ischemic Stroke","enrollment":1386},{"nctId":"NCT05657470","phase":"PHASE2, PHASE3","title":"Rescue Thrombolysis for Medium Vessel Occlusion (RESCUE-TNK)","status":"COMPLETED","sponsor":"General Hospital of Shenyang Military Region","startDate":"2023-03-21","conditions":"Stroke, Ischemic","enrollment":80},{"nctId":"NCT04965038","phase":"PHASE3","title":"Early Reperfusion Therapy With Intravenous Thrombolysis for Recovery of VISION in Acute Central Retinal Artery Occlusion","status":"RECRUITING","sponsor":"University Hospital Tuebingen","startDate":"2022-10-10","conditions":"Central Retinal Artery Occlusion","enrollment":422},{"nctId":"NCT06868511","phase":"PHASE3","title":"Neuronavigation-assisted Stereotactic Puncture With Tenecteplase for Acute Intracerebral Hemorrhage","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-04-25","conditions":"Deep Intracerebral Hemorrhage (ICH)","enrollment":732},{"nctId":"NCT05199194","phase":"PHASE3","title":"Randomization to Endovascular Treatment Alone or Preceded by Systemic Thrombolysis With Tenecteplase in Ischemic Stroke","status":"RECRUITING","sponsor":"Hospital Moinhos de Vento","startDate":"2022-05-27","conditions":"Stroke, Ischemic, Stroke, Acute","enrollment":398},{"nctId":"NCT05199662","phase":"PHASE3","title":"Randomization to Extend Stroke Intravenous ThromboLysis In Evolving Non-Large Vessel Occlusion With TNK (RESILIENT","status":"RECRUITING","sponsor":"Hospital Moinhos de Vento","startDate":"2022-01-20","conditions":"Ischemic Stroke, Acute","enrollment":466},{"nctId":"NCT04733742","phase":"PHASE2, PHASE3","title":"Endovascular Treatment With Versus Without Intravenous rhTNK-tPA in Stroke","status":"COMPLETED","sponsor":"Xinqiao Hospital of Chongqing","startDate":"2022-05-09","conditions":"Stroke, Acute, Stroke, Ischemic","enrollment":550},{"nctId":"NCT06571149","phase":"PHASE4","title":"Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake","status":"RECRUITING","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2025-03-14","conditions":"Ischemic Stroke","enrollment":906},{"nctId":"NCT05172934","phase":"PHASE2","title":"Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy Pilot Trial","status":"COMPLETED","sponsor":"ProMedica Health System","startDate":"2022-03-15","conditions":"Ischemic Stroke","enrollment":20},{"nctId":"NCT05635786","phase":"","title":"Early Recanalization After Intravenous Thrombolysis With Tenecteplase Versus Alteplase in Distal Vessel Occlusion Strokes","status":"COMPLETED","sponsor":"Centre Hospitalier Sud Francilien","startDate":"2023-01-02","conditions":"Acute Distal Vessel Occlusion Stroke","enrollment":319},{"nctId":"NCT06115070","phase":"PHASE4","title":"Intravenous Thrombolytic Therapy for Acute Ischemic Stroke Patients with Low NIHSS and Non-disabling Deficits","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-03-01","conditions":"Thrombosis, Acute Ischemic Stroke (AIS)","enrollment":390},{"nctId":"NCT03854500","phase":"PHASE3","title":"The Norwegian Tenecteplase Stroke Trial 2","status":"TERMINATED","sponsor":"Haukeland University Hospital","startDate":"2019-10-28","conditions":"Stroke, Acute, Cerebrovascular Disorders, Ischemic Stroke","enrollment":201},{"nctId":"NCT06814964","phase":"PHASE1","title":"rhTNK-tPA Thrombolytic Removal of Intraventricular Hemorrhage","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-03-01","conditions":"Intraventricular Hemorrhage","enrollment":18},{"nctId":"NCT06841965","phase":"PHASE3","title":"Intravenous Thrombolysis in Acute Ischemic Stroke with Active Cancer","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-03-01","conditions":"Stroke, Acute Ischemic Stroke","enrollment":280},{"nctId":"NCT06749834","phase":"PHASE3","title":"Intravenous Thrombolysis and NOAC","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-01-27","conditions":"Acute Ischemic Stroke","enrollment":280},{"nctId":"NCT06841978","phase":"PHASE3","title":"Intravenous Thrombosis and Patients with Prior Ischemic Stroke Within 3 Months","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-03-01","conditions":"Stroke, Acute Ischemic Stroke","enrollment":306},{"nctId":"NCT06833827","phase":"NA","title":"'Thrombectomy in High-Risk Pulmonary Embolism - Device Versus Thrombolysis Netherlands': TORPEDO-NL","status":"RECRUITING","sponsor":"Leiden University Medical Center","startDate":"2025-02","conditions":"Pulmonary Embolism Acute","enrollment":111},{"nctId":"NCT02398656","phase":"PHASE3","title":"A Randomized Controlled Trial of TNK-tPA Versus Standard of Care for Minor Ischemic Stroke With Proven Occlusion","status":"COMPLETED","sponsor":"University of Calgary","startDate":"2015-04-01","conditions":"Stroke, Acute","enrollment":1274},{"nctId":"NCT04454788","phase":"PHASE3","title":"Extending the Time Window for Tenecteplase by Effective Reperfusion in Patients with Large Vessel Occlusion","status":"TERMINATED","sponsor":"University of Melbourne","startDate":"2020-08-01","conditions":"Ischemic Stroke","enrollment":242},{"nctId":"NCT06352632","phase":"PHASE3","title":"ACT-GLOBAL Adaptive Platform Trial for Stroke","status":"RECRUITING","sponsor":"The George Institute","startDate":"2024-09-26","conditions":"Stroke","enrollment":20000},{"nctId":"NCT06621121","phase":"","title":"A Real-world Study of Tenecteplase Versus Alteplase for Thrombolysis in Patients Within 4.5 H of Onset of Ischemic Stroke","status":"RECRUITING","sponsor":"Tianjin Huanhu Hospital","startDate":"2024-10-26","conditions":"Stroke Acute, Tenecteplase, Alteplase","enrollment":6000},{"nctId":"NCT06559436","phase":"NA","title":"Extending the Time Window for Intravenous Tenecteplase in Patients With Distal Medium Vessel Occlusions Stroke","status":"RECRUITING","sponsor":"The First Affiliated Hospital of University of Science and Technology of China","startDate":"2024-10-02","conditions":"Acute Ischemic Stroke","enrollment":560},{"nctId":"NCT02777580","phase":"PHASE4","title":"STrategic Reperfusion in Elderly Patients Early After Myocardial Infarction","status":"COMPLETED","sponsor":"KU Leuven","startDate":"2017-08-01","conditions":"Myocardial Infarction","enrollment":609},{"nctId":"NCT05827042","phase":"PHASE3","title":"Endovascular Thrombectomy Alone Versus Intravenous Thrombolysis Plus Thrombectomy on Acute Basilar Artery Occlusion","status":"RECRUITING","sponsor":"The First Affiliated Hospital of University of Science and Technology of China","startDate":"2023-05-09","conditions":"Basilar Artery Occlusion, Acute Cerebrovascular Accident, Stroke Due to Basilar Artery Occlusion","enrollment":338},{"nctId":"NCT03998319","phase":"PHASE3","title":"A Study of Low-dose Intracoronary Thrombolytic Therapy in STEMI (Heart Attack) Patients.","status":"RECRUITING","sponsor":"University of Sydney","startDate":"2021-10-14","conditions":"STEMI, Elevated IMR (>32)","enrollment":445},{"nctId":"NCT06556446","phase":"","title":"Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants","status":"RECRUITING","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2024-01-01","conditions":"Ischemic Stroke","enrollment":2800},{"nctId":"NCT06498323","phase":"PHASE4","title":"Intravenous TNK vs TPA for AIS Treatment on MSU,a Prospective Multicenter RCT","status":"RECRUITING","sponsor":"Mahidol University","startDate":"2022-08-03","conditions":"Intravenous, Thrombosis, Acute Ischemic Stroke","enrollment":160},{"nctId":"NCT05203224","phase":"PHASE2","title":"Improving Early Reperfusion With Adjuvant Dornase Alfa in Large Vessel Ischemic Stroke (EXTEND-IA DNase)","status":"RECRUITING","sponsor":"University of Melbourne","startDate":"2022-02-18","conditions":"Ischemic Stroke","enrollment":300},{"nctId":"NCT02814409","phase":"PHASE3","title":"Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis","status":"COMPLETED","sponsor":"NHS Greater Glasgow and Clyde","startDate":"2016-12-15","conditions":"Ischemic Stroke","enrollment":1858},{"nctId":"NCT03785678","phase":"PHASE3","title":"Tenecteplase in Stroke Patients Between 4.5 and 24 Hours","status":"COMPLETED","sponsor":"Genentech, Inc.","startDate":"2019-03-02","conditions":"THROMBOLYSIS","enrollment":458},{"nctId":"NCT05684172","phase":"PHASE2, PHASE3","title":"Intra-arterial TNK Following Endovascular Thrombectomy in Patients With Large Vessel Occlusion of Posterior Circulation","status":"COMPLETED","sponsor":"The First Affiliated Hospital of University of Science and Technology of China","startDate":"2023-01-24","conditions":"Acute Ischemic Stroke, Intracranial Artery Occlusion, Endovascular Thrombectomy","enrollment":208},{"nctId":"NCT05900674","phase":"PHASE2","title":"Endovascular Stroke Treatment And Reteplase Protocol","status":"WITHDRAWN","sponsor":"Zeenat Qureshi Stroke Institute","startDate":"2023-07","conditions":"Ischemic Stroke","enrollment":""},{"nctId":"NCT05624190","phase":"PHASE4","title":"Intra-arterial Recombinant Human TNK Tissue-type Plasminogen Activator (rhTNK-tPA) Thrombolysis for Acute Large Vascular Occlusion After Successful Mechanical Thrombectomy Recanalization","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2023-02-16","conditions":"Ischemic Stroke, Acute","enrollment":256},{"nctId":"NCT05601999","phase":"PHASE3","title":"Study of Efficacy and Safety of GNR-060 vs Metalyse in Patients With ST Elevation Myocardial Infarction","status":"RECRUITING","sponsor":"AO GENERIUM","startDate":"2021-09-03","conditions":"ST Elevation Myocardial Infarction","enrollment":244},{"nctId":"NCT05105633","phase":"PHASE2, PHASE3","title":"Extending the Time Window for Tenecteplase by Recanalization of Basilar Artery Occlusion in Posterior Circulation Stroke","status":"RECRUITING","sponsor":"University of Melbourne","startDate":"2021-11-29","conditions":"Basilar Artery Occlusion","enrollment":688},{"nctId":"NCT04516993","phase":"PHASE2","title":"CHinese Acute Tissue-Based Imaging Selection for Lysis In Stroke -Tenecteplase II","status":"COMPLETED","sponsor":"Huashan Hospital","startDate":"2021-09-28","conditions":"Stroke","enrollment":224},{"nctId":"NCT05809921","phase":"","title":"Dual IntraVenous Thrombolysis Approach (DIVA) in Patients With Medium-vessel-occlusion Strokes: a Retrospective Study","status":"COMPLETED","sponsor":"Centre Hospitalier Sud Francilien","startDate":"2023-05-17","conditions":"Acute Ischemic Stroke Due to Medium-vessel-occlusion","enrollment":294},{"nctId":"NCT05733507","phase":"","title":"Tirofiban Plus Intravenous Thrombolysis in Acute Anterior Choroidal Infarction or Paramedian Pontine Infarction","status":"COMPLETED","sponsor":"Centre Hospitalier Sud Francilien","startDate":"2023-04-03","conditions":"Acute Anterior Choroidal Infarction (ACI), Paramedian Pontine Infarction (IPP)","enrollment":48},{"nctId":"NCT06078995","phase":"","title":"Tenecteplase Thrombolytic Therapy for Acute Ischemic Stroke in China","status":"UNKNOWN","sponsor":"Huashan Hospital","startDate":"2023-04-02","conditions":"Ischemic Stroke","enrollment":1200},{"nctId":"NCT03889249","phase":"PHASE3","title":"Alteplase Compared to Tenecteplase in Patients With Acute Ischemic Stroke","status":"COMPLETED","sponsor":"University of Calgary","startDate":"2019-12-10","conditions":"Stroke, Acute, Thromboses, Intracranial","enrollment":1600},{"nctId":"NCT04505592","phase":"PHASE2","title":"Tenecteplase in Patients With COVID-19","status":"COMPLETED","sponsor":"Hooman Poor","startDate":"2020-09-25","conditions":"COVID-19, Respiratory Failure, ARDS","enrollment":13},{"nctId":"NCT05745259","phase":"PHASE3","title":"Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-Ⅲ）","status":"UNKNOWN","sponsor":"Beijing Tiantan Hospital","startDate":"2022-10-26","conditions":"Acute Ischemic Stroke","enrollment":1630},{"nctId":"NCT05724342","phase":"","title":"Tenecteplase REperfusion in Acute Ischemic sTroke Registry（TREAT）","status":"UNKNOWN","sponsor":"Beijing Tiantan Hospital","startDate":"2023-02-15","conditions":"Stroke, Ischemic","enrollment":1600},{"nctId":"NCT05634382","phase":"PHASE3","title":"Endovascular Thrombectomy With and Without Intravenous Thrombolysis in Extended Time Window","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2022-12-03","conditions":"Stroke, Acute Ischemic","enrollment":222},{"nctId":"NCT02090712","phase":"","title":"Sao Paulo ST Segment Elevation Myocardial Infarction (STEMI) Registry","status":"UNKNOWN","sponsor":"Federal University of São Paulo","startDate":"2010-01","conditions":"Myocardial Infarction","enrollment":3000},{"nctId":"NCT05534360","phase":"","title":"Tenecteplase Treatment in Ischemic Stroke Registry","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2022-09","conditions":"Stroke, Acute","enrollment":5000},{"nctId":"NCT04752631","phase":"PHASE4","title":"MRI-guided thrOmbolysis for Stroke bEyond Time Window by TNK","status":"COMPLETED","sponsor":"General Hospital of Shenyang Military Region","startDate":"2021-03-09","conditions":"Stroke","enrollment":80},{"nctId":"NCT05281549","phase":"PHASE2","title":"Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-II）","status":"UNKNOWN","sponsor":"Beijing Tiantan Hospital","startDate":"2021-05-02","conditions":"Acute Ischemic Stroke","enrollment":225},{"nctId":"NCT04086147","phase":"PHASE2","title":"CHinese Acute Tissue-Based Imaging Selection for Lysis In Stroke -Tenecteplase","status":"COMPLETED","sponsor":"Huashan Hospital","startDate":"2019-12-09","conditions":"Stroke","enrollment":86},{"nctId":"NCT04071613","phase":"PHASE2","title":"Tenecteplase Versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance","status":"COMPLETED","sponsor":"Melbourne Health","startDate":"2019-06-20","conditions":"Stroke, Acute, Stroke Ischemic","enrollment":104},{"nctId":"NCT03181360","phase":"PHASE3","title":"Tenecteplase in Wake-up Ischaemic Stroke Trial","status":"UNKNOWN","sponsor":"University Hospital of North Norway","startDate":"2017-06-12","conditions":"Ischemic Stroke, Stroke, Acute","enrollment":600},{"nctId":"NCT01654445","phase":"PHASE2","title":"TNK-tPA Evaluation for Minor Ischemic Stroke With Proven Occlusion","status":"COMPLETED","sponsor":"University of Calgary","startDate":"2012-07","conditions":"Ischemic Stroke","enrollment":50},{"nctId":"NCT00639743","phase":"PHASE3","title":"PEITHO Pulmonary Embolism Thrombolysis Study","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2007-11-16","conditions":"Pulmonary Embolism","enrollment":1005},{"nctId":"NCT03340493","phase":"PHASE2","title":"Determining the Optimal Dose of Tenecteplase Before Endovascular Therapy for Ischaemic Stroke (EXTEND-IA TNK Part 2)","status":"COMPLETED","sponsor":"Neuroscience Trials Australia","startDate":"2017-12-06","conditions":"Ischemic Stroke","enrollment":300},{"nctId":"NCT01472926","phase":"PHASE2","title":"Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis- (ATTEST)","status":"COMPLETED","sponsor":"NHS Greater Glasgow and Clyde","startDate":"2011-12","conditions":"Stroke","enrollment":104},{"nctId":"NCT02338466","phase":"PHASE2","title":"Superiority of Rt-PA + Tenecteplase in Comparison With Rt-PA Only in Proximal Middle Cerebral Artery Occlusion","status":"WITHDRAWN","sponsor":"University Hospital Center of Martinique","startDate":"2016-07","conditions":"Nervous System Disorders, Cerebral Artery","enrollment":""},{"nctId":"NCT02101606","phase":"PHASE2","title":"Penumbral Based Novel Thrombolytic Therapy in Acute Ischemic Stroke","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2009-10","conditions":"Cerebral Infarction, Brain Ischemia, Stroke","enrollment":20},{"nctId":"NCT02388061","phase":"PHASE2","title":"Tenecteplase Versus Alteplase Before Endovascular Therapy for Ischemic Stroke","status":"COMPLETED","sponsor":"Neuroscience Trials Australia","startDate":"2015-03-23","conditions":"Ischemic Stroke","enrollment":202},{"nctId":"NCT01949948","phase":"PHASE3","title":"Study of Tenecteplase Versus Alteplase for Thrombolysis (Clot Dissolving) in Acute Ischemic Stroke","status":"COMPLETED","sponsor":"Lars Thomassen","startDate":"2012-09","conditions":"Ischemic Stroke","enrollment":1050},{"nctId":"NCT00257309","phase":"PHASE4","title":"Thrombolysis Versus Primary Angioplasty for AMI in Elderly Patients","status":"TERMINATED","sponsor":"Spanish Society of Cardiology","startDate":"2005-04","conditions":"Acute Myocardial Infarction","enrollment":266},{"nctId":"NCT02180204","phase":"PHASE2, PHASE3","title":"Tenecteplase Versus Alteplase in Ischemic Stroke Management (TALISMAN)","status":"WITHDRAWN","sponsor":"Reza Behrouz, DO","startDate":"2015-01","conditions":"Ischemic Stroke","enrollment":""},{"nctId":"NCT02268669","phase":"PHASE4","title":"Comparison of Primary PCI vs. Post-thrombolysis PCI as Reperfusion Strategies in STEMI","status":"UNKNOWN","sponsor":"GRACIA Group","startDate":"2010-05","conditions":"Myocardial Infarction","enrollment":1444},{"nctId":"NCT02194153","phase":"","title":"Surveillance of Patients With Suspected Acute Myocardial Infarction That Receive Early Inhospital Thrombolysis With Metalyse","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2001-05","conditions":"Myocardial Infarction","enrollment":351},{"nctId":"NCT02181985","phase":"PHASE3","title":"Full Dose Tenecteplase (TNK-tPA) Together With Heparin Sodium, Full Dose Tenecteplase With Enoxaparin, Half Dose Tenecteplase Together With Abciximab and Heparin Sodium in Patients With Acute Myocardial Infarction (AMI)","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2000-05","conditions":"Myocardial Infarction","enrollment":5989},{"nctId":"NCT02181998","phase":"PHASE3","title":"A Trial on Efficacy and Safety of Full Dose Tenecteplase Combined With Unfractionated Heparin (UFH) or Enoxaparin in Acute Myocardial Infarction (AMI) in the Prehospital Setting","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2000-07","conditions":"Myocardial Infarction","enrollment":1606}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":21,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["rhTNK-tPA"],"phase":"marketed","status":"active","brandName":"Tenecteplase thrombolysis","genericName":"Tenecteplase thrombolysis","companyName":"Xuanwu Hospital, Beijing","companyId":"xuanwu-hospital-beijing","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Tenecteplase is an exogenous protein used as an enzyme to activate tissue-type plasminogen activator, which is involved in the breakdown of blood clots. It is indicated for the treatment of conditions such as stroke, ischemic stroke, and cerebrovascular disorders, typically administered through intra-arterial injection or other methods.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}